Compare rec. lab reagents for research
Suppliers for Lab polyclonalsOur used polyclonals in Pubmed.
CAP® cell HCP ELISA Kit
Product name Calcyphosine (CAPS), ELISA Kit Full product name Human Calcyphosine ELISA Kit Product gene name CAPS kit ELISA For research use only For research use only. It should not be used in diagnostic procedures. Species reactivity: Human Preparation and Storage Store all reagents at 2-8 degrees C Product note Information selected from the online data sheet is extracted from bioinformatics databases, sometimes resulting in the ambiguous or...
HeLa HCP ELISA Kit
Product name: Hela human whole cell lysate SKU: LISADO0001 Description This cell lysate is prepared from human Hela cells using Boster's RIPA Lysis Buffer using a standard complete cell lysate protocol. The concentration was determined using the BCA assay procedure and then diluted using dithiothreitol (DTT) and reducing SDS sample loading buffer, heated for 5 minutes at 100°C. Expression Profiling: Read about HeLa cell gene expression and...
MDCK HCP ELISA Kit
Resume Glycosphingolipids (GSLs) from two Madin-Darby canine kidneys (MDCK) cell sublines, an epithelial cell line, were characterized by t.l.c., antibody overlay, and mass spectrometry. The main characteristic that distinguishes the two strains of MDCK cells is their transepithelial electrical resistance which is typically on the order of 3000 ohms.cm2 for the strain I cells and 100 ohms.cm2 for strain II cells. Cells from strains I and II were...
Identification and Characterization of a Novel Single Domain Antibody Against Ebola Virus
Ebola virus (EBOV) belongs to the Filoviridae household and causes extreme sicknesses equivalent to hemorrhagic fever with a excessive mortality fee as much as 90%. Now two antibody medication termed Inmazeb and Ebanga have been accredited for treating EBOV an infection. Nevertheless, scientific research have demonstrated that the mortality fee of the sufferers who obtained these two antibody medication stays above 30%. Subsequently, novel...
Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic
Regardless of substantial progress in confronting the worldwide HIV-1 epidemic since its inception within the 1980s, higher approaches for each therapy and prevention will probably be essential to finish the epidemic and stay a high public well being precedence. Antiretroviral remedy (ART) has been efficient in extending lives, however at a value of lifelong adherence to therapy. Broadly neutralizing antibodies (bNAbs) are directed to conserved...
SARS-CoV-2 Antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance
Background: Antibody response length following SARS-CoV-2 an infection tends to be variable and will depend on severity of illness and methodology of detection. Research design and strategies: COVID-19 convalescent plasma (CCP) from 18 donors was collected longitudinally for a most of 63 - 129 days following decision of signs. All of the samples have been initially screened by the Ortho Complete Ig check to substantiate positivity and...
Lowering the viscosity of a high-concentration antibody solution by protein-polyelectrolyte complex
Excessive-concentration and low-viscosity antibody formulations are vital when administering these options subcutaneously (SC) resulting from limitations on injection quantity. Right here we present a way to lower the viscosity of monoclonal antibody resolution by protein-polyelectrolyte advanced (PPC) with poly-l-glutamic acid (polyE). The viscosity of omalizumab options was 90 cP on the focus of 150 mg/mL. Within the presence of 20-50 mM...
Antibody drug conjugates for patients with breast cancer
The receptor-based classification of breast most cancers predicts its optimum remedy. Hormone Receptor (HR) optimistic breast most cancers is handled with endocrine remedy, and HER2+ illness is handled with HER2-targeted remedy. Triple destructive breast most cancers (TNBC), outlined as tumors missing HR and HER2, represents an aggressive subtype of breast most cancers related to poor prognosis. Growth of focused remedy for this subtype has...
Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection
Envelope protein-targeted vaccines for flaviviruses are restricted by issues of antibody-dependent enhancement (ADE) of infections. Nonstructural protein 1 (NS1) offers another vaccine goal that avoids this threat since this protein is absent from the virion. Past its intracellular function in virus replication, extracellular types of NS1 perform in immune modulation and are acknowledged by host-derived antibodies. The rational design of...